Company news

hVIVO plc news in 2026

hVIVO plc's news releases, calls and decks from 2026, newest first.

View company

Board appointment & Completion of Board evolution

November 2, 2026

Appointment of Chief Financial Officer

October 12, 2026

Chief Financial Officer Succession

September 15, 2026

HVIVO acquires CRS Berlin, expanding expertise into dermatology and women's health markets

August 27, 2026

H1 2026 Trading Update

July 23, 2026

Change of Auditor

July 13, 2026

Consultancy contract with Decoy Therapeutics

June 1, 2026

Grant of awards under Long Term Incentive Plan

May 29, 2026

£6m Influenza HCT contract signed

May 7, 2026

HCT contract signed with ILiAD Biotechnologies

April 22, 2026

Final Results 2025

April 15, 2026

hVIVO launches unified brand identity

April 14, 2026

Issue of Equity and Total Voting Rights

February 23, 2026

Trading Update

January 29, 2026

Notice of Trading Update

January 27, 2026

Calls in 2026

Decks in 2026